Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Neurotec Pharma
company
About
Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €3.30M
- Industries
- Biopharma,Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neurotec Pharma SL is a spin-off of the University of Barcelona (UB) founded in 2006 and based in the Parc CientÃfic de Barcelona (PCB).Neurotec centers its activity on developing new treatments for acute and chronic Central Nervous System (CNS) diseases. The proposed innovations are based in the possibility of controlling the activity of the microglia cells that are implicated in a wide group of diseases related to inflammation or acute cerebral damage.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€3.30M
Neurotec Pharma has raised a total of
€3.30M
in funding over 2 rounds. Their latest funding was raised on
Feb 19, 2011 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 19, 2011 | Series Unknown | €3.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Neurotec Pharma is funded by 1 investors.
Fundación Caja Navarra
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Fundación Caja Navarra
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
